<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet title="XSL_formatting" type="text/xsl" href="/~/media/Files/S/staar-surgical/XSL/rss_xsl.xsl"?> 
<rss version="2.0" xmlns:dt="http://xsltsl.org/date-time">
 <channel>
  <title>RSS - Staar Surgical - Press Releases </title>
  <link>https://investors.staar.com/rss/press-releases</link>
  <language>en</language>
<webMaster>Staar Surgical</webMaster>
<image>
<url>https://investors.staar.com/~/media/Images/S/staar-surgical/logo/logo-dark.svg</url>
</image>
<item>
<title><![CDATA[STAAR Surgical Appoints Warren Foust as President and Chief Executive Officer]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses for vision correction, today announced that following an extensive global search, its Board of Directors has appointed Warren Foust as President and Chief Executive Officer and a new member of the Board of Directors, effective August 4, 2026.]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/08-04-2026-210656803</link>
<pubDate>Tue, 04 Aug 2026 21:05:00 GMT</pubDate>
<publishDate>Tue, 04 Aug 2026 21:07:56 GMT</publishDate>
<guid>{38D87318-50C8-44FF-8848-525AF8A87B2C}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical to Host Second Quarter 2026 Earnings Results Call and Webcast on August 12, 2026]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses for vision correction, today announced that it will release financial results in combination with a shareholder letter for the second quarter ended July 3, 2026, on Wednesday, August 12, 2026, after the market close. The Company will also host an...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/08-04-2026-210126674</link>
<pubDate>Tue, 04 Aug 2026 21:01:00 GMT</pubDate>
<publishDate>Tue, 04 Aug 2026 21:02:53 GMT</publishDate>
<guid>{EFE4D4D6-0AC5-47BD-91D7-ACA2CEDE6994}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical Announces Preliminary Net Sales for Second Quarter 2026]]></title>
<description><![CDATA[The Company delivered strong second quarter net sales, led by sequential growth in China, solid growth across the broader Asia-Pacific region, and double-digit percentage growth in the Americas. In the EMEA region, net sales declined by a low single-digit percentage, reflecting ongoing turmoil in the Middle East; however, excluding the Middle East, EMEA...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/07-16-2026-210120790</link>
<pubDate>Thu, 16 Jul 2026 21:01:00 GMT</pubDate>
<publishDate>Thu, 16 Jul 2026 21:01:23 GMT</publishDate>
<guid>{EE4E22A0-D6E9-42F4-94BF-B9746671EA03}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical Announces Participation in Upcoming Investor Conferences]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses for vision correction, today announced that management will participate in the following upcoming conferences:. Stifel 2026 Virtual Ophthalmology Forum Date: Tuesday, May 26, 2026 Format: Meetings and Webcast Fireside Chat Details: Investor...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/05-21-2026-210114255</link>
<pubDate>Thu, 21 May 2026 21:01:00 GMT</pubDate>
<publishDate>Thu, 21 May 2026 21:02:52 GMT</publishDate>
<guid>{0256C7AA-F48A-4846-87C3-7BA4FA5BD078}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical Reports First Quarter 2026 Results; Issues Shareholder Letter]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses for vision correction, today reported results for the first quarter ended April 3, 2026.. Net sales of $93.5 million, up 119.6% Y/Y Net sales excluding China of $46.1 million, up 6.0% Y/Y Gross margin at 73.6% vs. 65.8% a year ago Net income of $5.2 million...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/05-13-2026-210133481</link>
<pubDate>Wed, 13 May 2026 21:01:00 GMT</pubDate>
<publishDate>Wed, 13 May 2026 21:06:47 GMT</publishDate>
<guid>{20625DC0-0CEC-47A4-AB46-BEDEF46DC84A}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical to Host First Quarter 2026 Earnings Results Call and Webcast on May 13, 2026]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses for vision correction, today announced that it will release financial results in combination with a shareholder letter for the first quarter ended April 3, 2026, on Wednesday, May 13, 2026, after the market close. The Company will also host an...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/05-04-2026-210121992</link>
<pubDate>Mon, 04 May 2026 21:01:00 GMT</pubDate>
<publishDate>Mon, 04 May 2026 21:01:22 GMT</publishDate>
<guid>{FFADCD1C-B797-4EA6-A8A3-8B1FAE2BAE3A}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical Announces Preliminary Net Sales for First Quarter 2026]]></title>
<description><![CDATA[Net sales for the first quarter of 2026 are expected to be in excess of $90 million, compared to net sales of $42.6 million for the first quarter of 2025.. “We are very pleased with our strong first quarter net sales in our largest market, China, which accounted for the majority of the increase in net sales, along with continued double-digit growth in the Americas.]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/04-08-2026-210110313</link>
<pubDate>Wed, 08 Apr 2026 21:01:00 GMT</pubDate>
<publishDate>Wed, 08 Apr 2026 21:01:12 GMT</publishDate>
<guid>{E993F198-C7F3-4563-A54D-19F4E4628F1F}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical Issues Shareholder Letter]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses for vision correction, today issued a Shareholder Letter on Tuesday, March 3 after the market close. STAAR’ s results release can be found here: https://investors.staar.com/news-and-events/press-releases. This past month marked an important...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/03-03-2026-210206703</link>
<pubDate>Tue, 03 Mar 2026 20:02:00 GMT</pubDate>
<publishDate>Tue, 03 Mar 2026 21:07:47 GMT</publishDate>
<guid>{8D0A7F09-1483-4CF6-B1C0-12CC67C5B40A}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical Reports Fourth Quarter and Fiscal Year 2025 Results]]></title>
<description><![CDATA[Net sales of $57.8 million, up 18.1% Y/Y Net sales excluding China of $40.3 million, down 2.1% Y/Y Gross margin at 75.7% vs. 64.7% Y/Y Net loss of$ million or$ per share, compared to a net loss of$ million or$ per share a year ago Adjusted EBITDA 1 breakeven or$ per share, compared to Adjusted EBITDA loss of$ million or$ per share a year ago. Net sales of $239.4 million, down 23.7%...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/03-03-2026-210122574</link>
<pubDate>Tue, 03 Mar 2026 20:01:00 GMT</pubDate>
<publishDate>Tue, 03 Mar 2026 21:07:47 GMT</publishDate>
<guid>{C4B511CF-76CE-486D-B296-BB90810A7BB3}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical Surpasses 4 Million ICLs Sold Globally, Reflecting Ongoing Shift Away from Laser-Based Vision Correction]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses for vision correction, today announced that more than 4 million Implantable Collamer ® Lenses have been sold worldwide, marking a milestone in the global shift away from laser-based refractive surgery. This achievement underscores the growing...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/02-25-2026-210120911</link>
<pubDate>Wed, 25 Feb 2026 20:01:00 GMT</pubDate>
<publishDate>Wed, 25 Feb 2026 21:01:23 GMT</publishDate>
<guid>{94899A5D-1ED8-4CE3-91AB-25ED7E1FC02E}</guid>
<isalertable>False</isalertable>
</item>

  
 </channel>
</rss>